# An Bioequivalence Study of Loxoprofen Sodium Patches in Healthy Volunteers

> **NCT06510413** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Frontier Biotechnologies Inc.** · enrollment: 40 (estimated)

## Conditions studied

- Osteoarthritis
- Muscle Pain
- Swelling Muscle

## Interventions

- **DRUG:** Loxoprofen Sodium Patches(reference product)
- **DRUG:** Loxoprofen Sodium Patches(test product )

## Key facts

- **NCT ID:** NCT06510413
- **Lead sponsor:** Frontier Biotechnologies Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-07
- **Primary completion:** 2024-08
- **Final completion:** 2024-08
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2024-07-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06510413

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06510413, "An Bioequivalence Study of Loxoprofen Sodium Patches in Healthy Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06510413. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*